Literature DB >> 25066225

CD271 is expressed in melanomas with more aggressive behaviour, with correlation of characteristic morphology by in vivo reflectance confocal microscopy.

F Beretti1, P Manni, C Longo, G Argenziano, F Farnetani, A M Cesinaro, A M Witkowski, A De Pol, G Pellacani.   

Abstract

BACKGROUND: Melanoma is the most highly aggressive type of skin cancer. Its resistance to existing treatments and the rapid rise in incidence underscore the importance of acquiring a better understanding of melanomagenesis.
OBJECTIVES: To assess the impact of reflectance confocal microscopy (RCM) on the description of cell morphology, which may influence the growth pattern and changes with increasing tumour severity, correlating with biological aspects.
METHODS: A retrospective analysis of 30 primary melanomas in vivo, evaluated by RCM, to correlate cell morphology and cellular arrangement with a marker of melanoma progression (CD271) using immunohistochemical evaluations.
RESULTS: Typical cells organized in dermal nests with peculiar in vivo confocal morphology result in melanoma with high malignancy and positivity to CD271. This architecture might be due to the presence of a type of cells, intrinsically predisposed to invasion, as a result of dedifferentiation programming, revealed by expression of the neural crest marker CD271.
CONCLUSIONS: With the hypothesis that dedifferentiated cells would be strongly responsible for initiation of tumour development and progression, we propose that CD271 detection could be associated with RCM evaluation in order to detect more aggressive melanoma subtypes.
© 2014 British Association of Dermatologists.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25066225     DOI: 10.1111/bjd.13301

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  6 in total

1.  An autophagy-driven pathway of ATP secretion supports the aggressive phenotype of BRAFV600E inhibitor-resistant metastatic melanoma cells.

Authors:  Shaun Martin; Aleksandra M Dudek-Peric; Abhishek D Garg; Heleen Roose; Seyma Demirsoy; Sofie Van Eygen; Freya Mertens; Peter Vangheluwe; Hugo Vankelecom; Patrizia Agostinis
Journal:  Autophagy       Date:  2017-07-19       Impact factor: 16.016

2.  Characterising the phenotypic evolution of circulating tumour cells during treatment.

Authors:  Simon Chang-Hao Tsao; Jing Wang; Yuling Wang; Andreas Behren; Jonathan Cebon; Matt Trau
Journal:  Nat Commun       Date:  2018-04-16       Impact factor: 14.919

3.  CD271 is a molecular switch with divergent roles in melanoma and melanocyte development.

Authors:  Fabian V Filipp; Chen Li; Alexander D Boiko
Journal:  Sci Rep       Date:  2019-05-22       Impact factor: 4.379

4.  CD271 determines migratory properties of melanoma cells.

Authors:  Josefine Radke; Florian Roßner; Torben Redmer
Journal:  Sci Rep       Date:  2017-08-29       Impact factor: 4.379

Review 5.  Tumor cell-intrinsic phenotypic plasticity facilitates adaptive cellular reprogramming driving acquired drug resistance.

Authors:  Heinz Hammerlindl; Helmut Schaider
Journal:  J Cell Commun Signal       Date:  2017-11-30       Impact factor: 5.782

6.  Harnessing autophagy to overcome mitogen-activated protein kinase kinase inhibitor-induced resistance in metastatic melanoma.

Authors:  S Verykiou; M Alexander; N Edwards; R Plummer; B Chaudhry; P E Lovat; D S Hill
Journal:  Br J Dermatol       Date:  2018-11-25       Impact factor: 9.302

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.